Articles by William Looney - Pharmaceutical Executive


Articles by William Looney

A Spark From GSK

Feb 1, 2014

Today, there is promise in new approaches that rely on the "other language of biology," using the human body's own circuitry of cells and nerves to induce precisely targeted therapeutic effects against a range of debilitating diseases.

Russian Innovation: A Higher Mark

Feb 1, 2014

For the first time, the spotlight shines on Russia's potential in biotechnology and pharma products

Takeda's Oncology Taskmaster

Feb 1, 2014

Millennium Takeda's new president, Anna Protopapas, explains the life choices that brought her from Cyprus to Cambridge—and a lead position in the hotly contested search to make cancer a treatable disease.

For Russia—Tough Love

Jan 21, 2014

Pharm Exec begins its 34th year with a feature on Russia's ambitious plans to build a homegrown biopharma business. Back in 1980, the biotech industry did not exst. Drugs were still classified as chemicals, developed from the random screening of many thoughts.

Russia's Bet on Biopharma

Jan 21, 2014

Can innovation trump ideology? Russia faces a stark choice in betting on the visible hand of government in promoting a "world class" biopharmaceutical sector, writes William Looney.

Big Stakes in Small Things

Dec 1, 2013

New and emerging technologies are noteworthy not simply for the excellent science behind them but also for the way they expose those raw edges of the industry's business model.

Executive Profile: United BioSource's Patrick Lindsay

Dec 1, 2013

For Patrick Lindsay, providing decision support across the full product life cycle is no stretch goal—it's today's fact of life

Pharm Exec Roundtable on Market Access

Nov 25, 2013

Pharm Exec convenes a diverse panel of experts to identify the key markers of common ground: its time, people, and money against that greatest intangible—hope.

Payers: Late for the Party?

Nov 1, 2013

Pharm Exec's two key features this month illustrate the strategic contradiction facing today's industry.


Click here